MBX
MBX Biosciences, Inc. Common Stock
NASDAQ: MBX · HEALTHCARE · BIOTECHNOLOGY
$28.61
-1.48% today
Updated 2026-04-29
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$9 – $45
Volume
0.5M
MBX Biosciences, Inc. Common Stock (MBX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-27.80%
ROA
-18.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-26.14M | — | — | — |
| 2023 | $0.00 | $-32.56M | — | — | — |
| 2024 | $0.00 | $-61.92M | — | — | — |
| 2025 | $0.00 | $-86.97M | — | — | — |